[A randomized controlled study of the VKORC1 and CYP2C9 genotypes in guiding warfarin therapy for pulmonary thromboembolism].

Jie Li, Shuang Liu, Jing-hua Yang, Wei Guo, Zengzhi Wang, Yong Chen, Shenghao WangPubMed 2013

Abstract

The warfarin stable dose prediction algorithm, containing genetic factors and non-heritage factors, can significantly shorten the adjustment time to reach warfarin stable dose, and reduce the incidence of side effects, and is clinically applicable.
BibTeX
@inproceedings{li2013randomized,
  author = {Jie Li and Shuang Liu and Jing-hua Yang and Wei Guo and Zengzhi Wang and Yong Chen and Shenghao Wang},
  title = {{[A randomized controlled study of the VKORC1 and CYP2C9 genotypes in guiding warfarin therapy for pulmonary thromboembolism].}},
  booktitle = {PubMed},
  year = {2013},
}

Loading related content...

Figure